Enveric Biosciences, Inc. (ENVB) Financials
ENVB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 6.6 million | 4.2 million |
| 2023-06-30 | 9.8 million | 4.9 million |
| 2023-03-31 | 15.9 million | 4.4 million |
| 2022-12-31 | 19.6 million | 4.0 million |
ENVB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -2.7 million | 372859 |
| 2023-06-30 | -4.5 million | 879738 |
| 2023-03-31 | -5.1 million | 532835 |
| 2022-12-31 | -3.5 million | 529372 |
ENVB Net Income
No data available :(
ENVB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 4.3 million | - | - |
| 2023-06-30 | 7.1 million | - | 9611 |
| 2023-03-31 | 12.6 million | - | 37044 |
| 2022-12-31 | 17.7 million | - | 63820 |
ENVB Shares Outstanding
ENVB Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 8 | 1.4 million | 2.0 million | - |
| 2023-06-30 | 18 | 2.5 million | 3.2 million | - |
| 2023-03-31 | 5169 | 2.0 million | 2.8 million | - |
| 2022-12-31 | 6193 | 1.9 million | 2.8 million | - |
ENVB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 95839 |
| 2023-06-30 | - | 114374 |
| 2023-03-31 | - | 113333 |
| 2022-12-31 | - | 90423 |
ENVB
Price: $0.92
52 week price:
Earnings Per Share: -8.09 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3818
Market Capitalization: 6.8 million